The University of Chicago Header Logo

Connection

Rita Nanda to Nanoparticles

Back to Details
This is a "connection" page, showing publications Rita Nanda has written about Nanoparticles.
Rita Nanda
Connection Strength
0.109
Nanoparticles
  1. TBCRC 019: A Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel with or without the Anti-Death Receptor 5 Monoclonal Antibody Tigatuzumab in Patients with Triple-Negative Breast Cancer. Clin Cancer Res. 2015 Jun 15; 21(12):2722-9.
    View in: PubMed
    Score: 0.109
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.